Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 16/2023

Content (10 Articles)

Alcohol-Associated Liver Disease: Evolving Concepts and Treatments

David Stephen Prince, Emily Nash, Ken Liu

Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

Arun Rajasekaran, Todd J. Green, Matthew B. Renfrow, Bruce A. Julian, Jan Novak, Dana V. Rizk

Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review

  • Gout
  • Review Article

Robert Terkeltaub

Continued Opioid Use and Adverse Events Following Provision of Opioids for Musculoskeletal Pain in the Emergency Department: A Systematic Review and Meta-Analysis

  • Open Access
  • Opioids
  • Systematic Review

Qiuzhe Chen, Chris G. Maher, Christopher S. Han, Christina Abdel Shaheed, Chung-Wei Christine Lin, Eileen M. Rogan, Gustavo C. Machado

Lotilaner Ophthalmic Solution 0.25%: First Approval

  • Open Access
  • Mites
  • AdisInsight Report

Yahiya Y. Syed

Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval

  • Open Access
  • Correction

Yahiya Y. Syed

Tafolecimab: First Approval

Susan J. Keam

Pozelimab: First Approval

Sheridan M. Hoy

Zuranolone: First Approval

Young-A Heo

Correction to: Rozanolixizumab: First Approval

Sheridan M. Hoy

Oct 23
Issue: 15/2023
Nov 23
Issue: 17/2023

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images